Financhill
Sell
32

KMTS Quote, Financials, Valuation and Earnings

Last price:
$22.58
Seasonality move :
--
Day range:
$22.21 - $23.09
52-week range:
$20.00 - $26.15
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
22.51x
P/B ratio:
--
Volume:
101.4K
Avg. volume:
115.5K
1-year change:
--
Market cap:
$1.1B
Revenue:
$27.5M
EPS (TTM):
--

Earnings Data

Next earnings date for KMTS
Aug 15
2025
Most recent earnings per share
-$0.28
Missed by $0.28
(Jul 31/2021)
Consensus Estimate
--
(Jul 31/2021)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

KMTS Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
08/15/2025 Q3 $17.5M -- -- -$0.48 --
05/15/2025 Q2 $15.7M -- -- -$0.53 --
04/14/2025 Q1 $15.1M -- -- -$0.64 --
10/31/2024 Q4 $14.7M -- -- -$0.55 --
07/31/2024 Q3 $12.8M -- -- -$0.54 --
07/31/2021 Q3 -- -- -$0.28 -- --
07/31/2020 Q3 -- -- -$0.17 -- --

Kestra Medical Technologies Earnings Questions

  • How Much did Kestra Medical Technologies Generate in Revenue Last Quarter?

    Kestra Medical Technologies reported -- worth of top line sales in its most recent quarter.

  • Did Kestra Medical Technologies Beat Earnings Last Quarter?

    Kestra Medical Technologies announced earnings per share of -$0.28 which represents a miss of analyst forecast a -- per share.

  • Is Kestra Medical Technologies Profitable?

    Kestra Medical Technologies reported -- that represents -- per share over the last quarter.

  • What is the Analyst Consensus for Kestra Medical Technologies EPS Next Year?

    Kestra Medical Technologies's earnings are forecast to decrease from -$0.96 per share to -$2.20 per share next year representing a decrease of -129.35%.

  • When is Kestra Medical Technologies's Earnings Date?

    Kestra Medical Technologies's next earnings date is August 15, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Where Will Salesforce Stock Be in 5 Years?
Where Will Salesforce Stock Be in 5 Years?

Salesforce (NYSE: CRM) just turned in a quarter that, on…

2 Ultra Safe Dividend Stocks to Buy Now
2 Ultra Safe Dividend Stocks to Buy Now

Historically, blue-chip dividend stocks have been good choices for periods…

Where Will Asana Stock Be in 5 Years?
Where Will Asana Stock Be in 5 Years?

Asana stock hasn’t given many investors on Wall Street any…

Stock Ideas

Buy
67
Is MSFT Stock a Buy?

Market Cap: $3.4T
P/E Ratio: 39x

Buy
65
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 46x

Sell
40
Is AAPL Stock a Buy?

Market Cap: $3T
P/E Ratio: 33x

Alerts

Sell
31
REGN alert for May 31

Regeneron Pharmaceuticals [REGN] is down 19.04% over the past day.

Buy
55
RGC alert for May 31

Regencell Bioscience Holdings [RGC] is up 16.13% over the past day.

Sell
42
AMBA alert for May 31

Ambarella [AMBA] is down 15.13% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock